Minneapolis, Minnesota
The University of Minnesota is one of USTMA’s central academic research sites. Marshall Mazepa, MD is a clinical researcher specializing in rare blood disorders and thrombotic microangiopathies and is a co-founder of the USTMA Consortium.
Minnesota maintains an active TTP research program that includes the P200 clinical data and biospecimen repository, clinical studies, and investigation of long-term neurologic and cognitive outcomes after TTP.
Marshall Mazepa is a USTMA investigator affiliated with University of Minnesota and is associated with an active P200 Registry site.
View profile →